TrialJournal of diabetes investigation2020

Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial.

Hajime Yamakage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.